EHA news


EHA news

Survey Monitoring H2020 – your input is needed!


Dear Colleague,

We need your input to improve Horizon 2020 and the next Research and Innovation Framework Programme of the European Union.

The European Commission is planning the interim evaluation of Horizon 2020 which will be crucial to the future of biomedical research funding in Europe. To influence this process, we, the biomedical research community, must feed your and your colleagues’ experiences and opinions with Horizon 2020 into this evaluation.

  • The survey should take approximately 10 minutes of your time.
  • Please ask your colleagues to fill out this survey as well. This makes the survey better and increases the volume of our ‘voice’.
  • Your input will help us to provide European institutions with strategic recommendations.
  • We look forward to receiving your answers no later than October 22, 2015.

So, if you have or have had any experience with Horizon 2020, you are kindly asked to fill out the survey here:

Thank you for your support.
With kind regards, sincerely,

Professor Ulrich Jäger
Chair of the EHA EU Affairs Committee
Member of the BioMed Alliance Board of Directors and
Chair of the Monitoring Horizon 2020 Task Force

The Alliance for Biomedical Research in Europe (Biomed Alliance)

The Alliance for Biomedical Research in Europe (BioMed Alliance) is a unique initiative representing 21 leading European biomedical societies that together include more than 400,000 researchers and health professionals across Europe.
The organization’s aim is to facilitate and promote excellence in health and biomedical research, through advocacy and specific actions, at European level.


Read more »

IMI2 Call for Research Proposals

On October 6, 2015, the Innovative Medicines Initiative (IMI) launched its 6th Call for proposals under IMI 2. This call includes, under the program “Big Data for Better Outcomes programme”, the topic:
Development of an outcomes-focused platform to empower policy makers and clinicians to optimize care for patients with hematologic malignancies.

Read more »

The European Union must deliver funding for research of blood disorders

At the Congress of the European Hematology Association (EHA) – attracting 10,000 hematologists from Europe and beyond - the president of EHA, Prof. Christine Chomienne, called upon the European Union to deliver funding for Research into Blood Disorders:

“The hematologists in Europe have done a great work. Now it’s the EU’s turn to deliver.”

Read more »